Europe Intra Articular Injection For Osteoarticular Infiltrations Market Scope And Analysis

  • Report Code : TIPRE00039338
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 92
Buy Now

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Scope 2031

Buy Now


Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Report Scope

Report Attribute Details
Market size in 2023 US$ 97.43 Million
Market Size by 2031 US$ 157.08 Million
Global CAGR (2023 - 2031) 6.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Type 1 Collagen
  • Hyaluronic Acid
By End User
  • Hospitals
  • Orthopedic Clinics
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Bioventus Inc
  • SEIKAGAKU CORPORATION
  • Maxigen Biotech Inc
  • stem Medical Inc
  • Sanofi SA
  • Ferring Pharmaceuticals
  • Fidia Pharma USA Inc
  • Biotech Healthcare Group
  • Bioteck S p A
  • I MED
  • Europe Intra-Articular Injection for Osteoarticular Infiltrations Market News and Recent Developments

    The Europe intra-articular injection for osteoarticular infiltrations market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Europe intra-articular injection for osteoarticular infiltrations market are listed below:

    • Maxigen Biotech Inc. (MBI) signed an exclusive distribution agreement with Mars Medicine Sa?l?k Ürünleri Limited ?irketi, one of the largest distributors of pharmaceutical products in Turkey, as Maxigen Biotech’s long-term, strategic partner in opening the Turkish market. This partnership aims to provide the best intra-articular injection technology to medical institutions in Turkey by supplying MBI’s products, which offer patients a full range of knee treatment solutions. Due to Turkey’s crucial location between the Middle East and Europe, this alliance will accelerate MBI’s expansion in those markets. (Source: Maxigen Biotech Inc., Press Release, November 2022)
    • Contura Orthopaedics Ltd collaborated with Horizon Lab Company, one of Italy’s leading independent medical device distributors, to promote patient access to its unique treatment—Arthrosamid—in Europe. (Source: Contura Orthopaedics Ltd, Press Release, June 2022)

    Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Report Coverage and Deliverables

    The “Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Europe intra-articular injection for osteoarticular infiltrations market size and forecast at regional and country levels for all the key market segments covered under the scope
    • Europe intra-articular injection for osteoarticular infiltrations market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST and SWOT analysis
    • Europe intra-articular injection for osteoarticular infiltrations market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Europe intra-articular injection for osteoarticular infiltrations market
    • Detailed company profiles